Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find the latest news about Atriva Therapeutics aggregated by PharmaCompass.com.

    Client Virtual Booth

    ATRIVA THERAPEUTICS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Atriva Therapeutics
    Germany Flag
    Country
    Country
    Germany
    Address
    Address
    Christophstrasse 32, 72072 Tuebingen
    Telephone
    Telephone
    +49 (0) 7071 8597673
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.atriva-therapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/atriva-therapeutics-gmbh/
    Twitter
    Twitter
    https://twitter.com/AtrivaTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Atriva Announces Exclusive Letter Agreement for Reverse Takeover Transaction
    Atriva Announces Exclusive Letter Agreement for Reverse Takeover Transaction

    https://www.globenewswire.com//news-release/2023/09/18/2744869/0/en/Atriva-Therapeutics-Announces-Exclusive-Letter-Agreement-for-Reverse-Takeover-Transaction-with-Biocure-Technology.html

    GLOBENEWSWIRE
    18 Sep 2023
    Share Share
    Edesa finds a signal in severely ill Covid-19 patients
    Edesa finds a signal in severely ill Covid-19 patients

    https://www.evaluate.com/vantage/articles/news/trial-results/edesa-finds-signal-severely-ill-covid-19-patients

    Elizabeth Cairns EVALUATE
    21 Sep 2021
    Share Share
    Atriva Therapeutics begins patient dosing in phase II RESPIRE trial in Covid-19
    Atriva Therapeutics begins patient dosing in phase II RESPIRE trial in Covid-19

    http://www.pharmabiz.com/NewsDetails.aspx?aid=137786&sid=2

    PHARMABIZ
    14 Apr 2021
    Share Share
    Atriva Therapeutics Doses First Patient in Phase II RESPIRE trial in COVID-19
    Atriva Therapeutics Doses First Patient in Phase II RESPIRE trial in COVID-19

    https://www.dgap.de/dgap/News/corporate/atriva-therapeutics-doses-first-patient-phase-respire-trial-covid/?newsID=1434547

    DGAP
    13 Apr 2021
    Share Share
    Artiva Biotherapeutics Raises $120 Million in Series B Financing
    Artiva Biotherapeutics Raises $120 Million in Series B Financing

    https://www.businesswire.com/news/home/20210226005084/en

    BUSINESSWIRE
    26 Feb 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search